Back to company

ABL BIOTEC A/S: Financial statements 2016

CVR: 50811018

ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -117,780 and a net result of DKK 795,892 compared with DKK 2,230,370 the year before. Equity amounted to DKK 24,538,583. The solvency ratio was 99.3%. The company had 1 employee in the financial year.

Gross Profit
-117,780 kr.
Profit/Loss
795,892 kr.
Equity
24,538,583 kr.
Total Assets
24,700,377 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016--118 t.796 t.24.5 mio.1
2015--122 t.2.2 mio.24.8 mio.-
2014--100 t.3.8 mio.23.7 mio.-
2013--97 t.2.7 mio.22.4 mio.-
2012--51 t.3.7 mio.21.5 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ABL BIOTEC A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

ABL BIOTEC A/S appoints new auditorMay 1, 2016

As of May 1, 2016, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of ABL BIOTEC A/S.

Auditor steps down at ABL BIOTEC A/SMay 1, 2016

As of May 1, 2016, MJAKP P/S has stepped down as auditor of ABL BIOTEC A/S.

ABL BIOTEC A/S: The 2015 annual report is outApr 1, 2016

ABL BIOTEC A/S has published its annual report for 2015. Gross profit came to DKK -122,431, and the net result was DKK 2,230,370.

About ABL BIOTEC A/S

ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Asger Bach-Larsen. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 0 employees. In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity amounted to DKK 27,884,586.